RE:RE:Any company’s management team has a duty to maximize Rumpl3StiltSkin wrote Jaro1977 wrote: shareholders value!
I think at least now, that TLT is involved with Li Ka Shing Institute, we will have the financing going forward if the CR % numbers keep improving. We should get regular patient CR data updates with each quarterly report. IF you can afford to buy more shares of TLT? NOW is the time! The writing on the wall Rumpl3StiltSkin is much easier to read now that the move as per (TLT) news release with Li Ka Shing Institute. I can only guess as you say "if CR% keeps improving " that many doors will open for far less dilution at substantially higher prices. Of course in my thoughts is the big question does this push a buyout or partnership further down the road or even is there now a need for buyout/partnership with a giant like Li Ka Shing/Institute in the picture. Debate on this board on the subject on buyout or partnership I think favors the longer Theralase can go without either then the higher the share price will rise. The looming question will Theralase evolve into a large international biopharmaceutical!